Bharat Parenterals Limited share price
NSE: BPLPHARMA · ISIN INE365Y01019
Key numbers
- Market cap
- -
- Current price
- ₹ 1,898.00
- 52-week high / low
- ₹ 1,898 / 1,201
- Stock P/E
- -
- Book value
- ₹ 795.6
- Dividend yield
- 0.05%
- ROCE
- -2.0%
- ROE
- -2.5%
- Debt to equity
- 0.45
- Sales growth (3 yrs)
- 16.4%
- Profit growth (3 yrs)
- -
- 1-year return
- -
About Bharat Parenterals Limited
Bharat Parenterals Limited engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India and internationally. The company provides antibiotics, cardiovascular and central nervous system, antifungal, antimalarial, gastrointestinal tract/alimentary systems, analgesics, anaesthetics, quinolones, erectile dysfunction medicines, nutritional supplements, steroids and hormones, and other drugs. It also engages in manufacturing general products in capsules, tablets, ointment and creams, injections, oral liquids, and powder sachets forms; and beta lactum and cephalosporin products in capsules, tablets, dry syrup, and powder for injection forms. In addition, it offers research, development and manufacture of pharmaceutical formula ons, including sterile injectable products, oral liquid formula ons, prefilled syringes, other specialty, and eye drops. Bharat Parenterals Limited was incorporated in 1992 and is based in Vadodara, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 116 | 65 | 65 | 100 | 94 |
| Operating profit | 14 | 1 | 2 | -1 | 9 |
| Net profit | 8 | -7 | -5 | -5 | 1 |
| EPS (₹) | 11.94 | -14.00 | -14.03 | -11.84 | 1.46 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.